Skip to main content
    T

    Tela Bio Inc (TELA)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $1.01
    -0.09 (-7.76%)

    Market Cap: $49.43M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    28%(8/29)
    Avg Surprise
    -11.86%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.15
    Range$-0.21 - $-0.13
    6 analysts
    EPS RevisionsNo revisions (7d)
    3
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.15-3.3%
    60d ago$-0.15-3.3%
    30d ago$-0.15-2.0%
    7d ago$-0.16+1.9%
    Current$-0.15
    Revenue Consensus
    $20M
    Range$19M - $21M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-0.17
    Range$-0.24 - $-0.12
    6 analysts
    Revenue Consensus
    $21M
    Range$19M - $22M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.17---
    Sep 26EST
    		-$-0.15---
    Jun 26
    Reported Aug 10
    		$-0.20$-0.17-17.65%Miss+9.1%
    Mar 26
    Reported May 12
    		$-0.21$-0.15-39.86%Miss+14.2%
    Dec 25
    Reported Mar 25
    		$-0.17$-0.18+5.56%Beat+26.1%
    Sep 25
    Reported Nov 13
    		$-0.19$-0.20+5.00%Beat+54.8%
    Jun 25
    Reported Aug 11
    		$-0.22$-0.18-22.22%Miss+56.9%
    Mar 25
    Reported May 8
    		$-0.25$-0.21-19.05%Miss+53.7%
    Dec 24
    Reported Mar 20
    		$-0.23$-0.22-3.60%Miss+56.6%
    Sep 24
    Reported Nov 7
    		$-0.42$-0.42+0.00%Beat+6.7%
    Jun 24
    Reported Aug 12
    		$-0.51$-0.47-8.51%Miss-10.9%
    Mar 24
    Reported May 9
    		$-0.54$-0.51-5.88%Miss+14.3%
    Dec 23
    Reported Mar 21
    		$-0.53$-0.43-23.26%Miss-1.9%
    Sep 23
    Reported Nov 9
    		$-0.45$-0.27-66.67%Miss+29.7%
    Jun 23
    Reported Aug 9
    		$-0.46$-0.52+11.54%Beat+41.8%
    Mar 23
    Reported May 11
    		$-0.63$-0.56-12.50%Miss+16.0%
    Dec 22
    Reported Mar 21
    		$-0.52$-0.54+3.70%Beat+11.9%
    Sep 22
    Reported Nov 9
    		$-0.64$-0.56-14.29%Miss-12.3%
    Jun 22
    Reported Aug 10
    		$-0.79$-0.62-27.42%Miss-38.6%
    Mar 22
    Reported May 10
    		$-0.75$-0.56-33.93%Miss-33.9%
    Dec 21
    Reported Mar 21
    		$-0.59$-0.55-7.27%Miss-9.3%
    Sep 21
    Reported Nov 10
    		$-0.57$-0.52-9.62%Miss-7.5%
    Jun 21
    Reported Aug 11
    		$-0.57$-0.52-9.62%Miss-7.5%
    Mar 21
    Reported May 13
    		$-0.56$-0.48-16.67%Miss+11.1%
    Dec 20
    Reported Mar 24
    		$-0.54$-0.49-10.20%Miss+5.3%
    Sep 20
    Reported Nov 11
    		$-0.53$-0.48-10.42%Miss+10.2%
    Jun 20
    Reported Aug 12
    		$-0.53$-0.59+10.17%Beat-12.8%
    Mar 20
    Reported May 12
    		$-0.63$-0.56-12.50%Miss-
    Dec 19
    Reported Mar 27
    		$-0.57$-0.59+3.39%Beat-
    Sep 19
    Reported Nov 8
    		$-0.59$-0.45-31.11%Miss-
    Jun 19
    Reported Aug 28
    		$-0.47$-0.58+18.97%Beat-

    Key Metrics

    Valuation
    P/E Ratio-1.30EV/EBITDAN/A
    Price/FCF-1.83xFCF Yield-54.53%
    Profitability
    Profit Margin-51.50%Operating Margin-48.10%
    ROE-617.00%ROIC-82.21%
    Financial Health
    Debt/Equity-3.53xInterest Coverage-4.21x
    Current Ratio2.99xQuick Ratio2.38x
    Trading Statistics
    Beta1.36Avg Volume216.38K
    52-Week High$1.5652-Week Low$0.50

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.08
    SMA 20$1.18
    SMA 50$0.95
    SMA 200$0.86
    EMA 10$1.09
    EMA 20$1.10
    EMA 50$1.01
    EMA 200$0.95

    MACD

    Line: 0.02Signal: 0.05Hist: -0.03

    ADX

    ADX: 40.5+DI: 20.0-DI: 14.8

    Aroon & PSAR

    Aroon Up36.0
    Aroon Down4.0
    PSAR$1.14

    Bollinger Bands

    Upper Band$1.39
    Lower Band$0.96
    %B Position3638%(Upper)
    Band Width0.11

    RSI (14-Day)

    Neutral
    44.5

    Momentum Oscillators

    Stoch %K19.2
    Stoch %D19.7
    Williams %R-90.5
    ROC (10d)-19.2%
    Momentum-0.24
    CCI (20d)-116.5
    MFI (14d)37.8

    Volatility Measures

    ATR (14d)$0.12(11.7%)
    StdDev (20d)0.11
    Hist Vol80.5%(High)

    Volume Flow

    VWAP$1.04
    OBV-776.7K
    AD Line-4.5M
    CMF (20d)-0.211

    Volume Metrics

    Avg Vol (20d)195.1K
    Vol Ratio1.2x
    VWMA (20d)$1.20

    Pivot Points

    R3$1.24
    R2$1.18
    R1$1.14
    Pivot Point$1.08
    S1$1.04
    S2$0.98
    S3$0.94

    Advanced Oscillators

    TSI5.13
    Ultimate Osc41.8
    KST277.66

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$19.29M$19.06M$20.87M$20.69M$20.20M$18.52M$17.65M$18.96M$16.09M$16.60M$17.00M$15.05M
    Cost of Revenue$5.25M$6.44M$6.73M$6.72M$6.00M$5.91M$6.43M$6.10M$5.02M$5.27M$4.99M$4.66M
    Gross Profit$13.94M$12.52M$13.76M$13.97M$14.11M$12.51M$11.22M$12.86M$11.07M$11.34M$11.62M$10.39M
    Operating Expenses$23.23M$23.05M$20.40M$21.52M$23.19M$22.98M$19.57M$22.22M$22.64M$16.16M$23.90M$20.57M
    R&D$2.72M$2.34M$2.13M$2.35M$2.20M$2.54M$2.03M$2.07M$2.32M$2.39M$2.69M$2.37M
    SG&A$4.06M$4.17M$3.78M$3.95M$4.13M$3.84M$3.59M$3.68M$3.62M$3.83M$4.05M$3.73M
    Operating Income$-9,283,000$-10,526,000$-6,648,000$-7,554,000$-9,081,000$-10,472,000$-8,354,000$-9,365,000$-11,570,000$-4,826,000$-12,278,000$-10,181,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2.08M$2.05M$2.52M$1.20M$1.19M$1.22M$1.28M$1.34M$1.33M$1.33M$1.34M$1.33M
    Income Before Tax$-11,202,000$-12,213,000$-8,896,000$-8,603,000$-9,890,000$-11,212,000$-9,352,000$-10,372,000$-12,600,000$-5,661,000$-12,890,000$-10,957,000
    Income Tax Expense$60,000$60,000$145,000$0$33,000$52,000$-144,000$0$0$0$0$0
    Net Income$-11,262,000$-12,273,000$-9,041,000$-8,603,000$-9,923,000$-11,264,000$-9,208,000$-10,372,000$-12,600,000$-5,661,000$-12,890,000$-10,957,000
    EBITDA$-8,860,000$-9,896,000$-6,146,000$-7,154,000$-8,432,000$-9,726,000$-7,803,000$-8,765,000$-11,020,000$-4,095,000$-11,384,000$-9,405,000
    EBIT$-9,126,000$-10,160,000$-6,371,000$-7,402,000$-8,702,000$-9,993,000$-8,069,000$-9,028,000$-11,269,000$-4,329,000$-11,545,000$-9,623,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TELA

    Government Contracts

    Gov Obligations (TTM)
    $11025
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    1
    Avg Remaining Term
    N/A

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    36C26126P0059Department of Veterans AffairsDepartment of Veterans Affairs$11025Nov 3, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    TELA Bio Wins FDA Clearance for Resorbable Surgical Mesh

    TELA Bio Inc. has received FDA 510(k) clearance for its Liora Monofilament Scaffold, a fully resorbable synthetic surgical mesh. This marks the company's first in-house designed and produced synthetic product...

    MyChesCo•10/14/26•Bullish

    TELA Bio Regains Nasdaq Compliance, Securing Listing Status

    TELA Bio Inc. (TELA) has successfully regained compliance with Nasdaq's minimum bid price requirement for continued listing on the Nasdaq Global Market. This resolution removes the risk of delisting...

    The Globe and Mail•10/8/26•Bullish

    TELA Bio regains Nasdaq Global Market minimum bid price compliance

    TELA Bio (TELA) has regained compliance with Nasdaq's minimum bid price requirement, ensuring its continued listing on the Nasdaq Global Market. Nasdaq confirmed compliance with Listing Rule 5450(a)(1) on October 5...

    TradingView•10/7/26•Bullish

    TELA Bio Achieves Nasdaq Minimum Bid Price Compliance, Listing Issue Resolved

    TELA Bio, Inc. has announced that it has regained compliance with Nasdaq's minimum bid price requirement for continued listing on the Nasdaq Global Market. The company received confirmation from The Nasdaq Stock Market...

    Kalkine Media•10/6/26•Bullish

    TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

    TELA Bio, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration for its Liora Monofilament Scaffold. This fully resorbable surgical mesh device is the first synthetic product in TELA Bio's...

    GlobeNewswire•10/6/26•Bullish

    TELA Valuation and Fair Value

    P/E
    -1.3x
    P/FCF
    -1.8x
    P/B
    -3.7x
    See GNG's fair value

    TELA Profitability: Margins, ROIC and FCF

    Gross margin
    67.8%
    Operating margin
    -48.1%
    Net margin
    -51.5%
    ROIC
    -82.2%
    ROE
    -617.0%
    FCF margin
    -39.6%
    FCF yield
    -54.5%

    TELA Competitors

    CompanyTicker
    iBio, Inc. Common StockIBIO
    Mereo BioPharma Group PLC ADRMREO
    Myomo IncMYO
    Envoy Medical Inc.COCH
    Alterity Therapeutics LtdATHE
    Klotho Neurosciences, Inc.KLTO
    Mink Therapeutics IncINKT
    Elicio Therapeutics Inc.ELTX

    Sector: Healthcare

    TELA Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    3
    Hold
    1
    Sell
    0
    Strong Sell
    0

    TELA Bull Case vs Bear Case

    Bull case

    • 80.0% of TELA's analyst ratings are Buy or Strong Buy.

    Bear case

    • TELA has a -51.5% net profit margin.
    • TELA beat EPS estimates in 25.0% of its last 8 reported quarters.
    • TELA's quarterly revenue changed -4.5% year over year.

    TELA Earnings: Beat Rate and Next Report

    Beat rate
    2 of 8 quarters (25.0%)
    Average surprise
    -11.5%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.15
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    3 up, 2 down

    Frequently Asked Questions About TELA

    Does TELA pay dividends?

    Tela Bio Inc (TELA) does not currently pay a regular dividend.

    What is TELA's market cap?

    Tela Bio Inc (TELA) has a market capitalization of $49.43M with a current stock price of $1.01.

    Related stocks

    Sector: Healthcare

    All stocks starting with T

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In